Invention Grant
![Substituted dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones as RIPK3 inhibitors](/docs/US/2019-05-28/US10301306B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones as RIPK3 inhibitors
-
Application No.: US15527343Application Date: 2015-12-14
-
Publication No.: US10301306B2Publication Date: 2019-05-28
- Inventor: Amy C. Hart , William J. Pitts , Harold Mastalerz , Junqing Guo , Gregory D. Brown
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Hong Liu
- International Application: PCT/US2015/065466 WO 20151214
- International Announcement: WO2016/100166 WO 20160623
- Main IPC: C07D471/04
- IPC: C07D471/04
![Substituted dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones as RIPK3 inhibitors](/abs-image/US/2019/05/28/US10301306B2/abs.jpg.150x150.jpg)
Abstract:
Compounds having Formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, are useful as kinase modulators, including RIPK3 modulation. All the variables defined herein.
Public/Granted literature
- US20170362219A1 SUBSTITUTED DIHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-4(5H)-ONES AS RIPK3 INHIBITORS Public/Granted day:2017-12-21
Information query
